The impact of the new GP contract on measurement of lipids and use of statins in the over 80s with coronary heart disease

Samira Siddiqui, Chris Isles, Ewan Bell, Alan Begg

Research output: Contribution to journalArticlepeer-review

Abstract

The benefits of statins for both primary and secondary prevention of coronary heart disease (CHD) are limited mainly to patients under 80. We examined the impact of the new General Medical Services (GMS) contract on measurement of lipids and prescribing of statins in patients over 80 years of age with CHD. We found that there has been a significant increase in both, with little evidence supporting this and substantial financial implications. National guidance on the assessment and management of lipids in the over 80s in the new GMS contract is urgently required.

Original languageEnglish
Pages (from-to)367-369
Number of pages3
JournalBritish Journal of Cardiology
Volume13
Issue number5
Publication statusPublished - Sep 2006

Keywords

  • Coronary heart disease
  • General practice
  • Octogenarians
  • Statins

Fingerprint Dive into the research topics of 'The impact of the new GP contract on measurement of lipids and use of statins in the over 80s with coronary heart disease'. Together they form a unique fingerprint.

Cite this